Journal of autism and childhood schizophrenia

, Volume 1, Issue 3, pp 267–282 | Cite as

Imipramine in preschool autistic and schizophrenic children

  • Magda Campbell
  • Barbara Fish
  • Theodore Shapiro
  • Arthur FloydJr.

Abstract

Imipramine was studied in 10 autistic and schizophrenic children 2 to 6 years of age, whose intellectual functioning ranged from low average and mild to severe mental retardation. The purpose of this pilot study was to explore the effects of imipramine in this patient population. Imipramine showed a mixture of stimulating, tranquilizing, and disorganizing effects. Three children improved markedly, 3 slightly, and 5 became worse (nonblind evaluations). Only 2 were rated improved by the “blind” psychiatrist. In general, this was not a good drug for this group of children. The overall effect was infrequently therapeutic and usually outweighed by the toxic effects. Epileptogenic effect, effect on psychosis, as well as possible mechanisms of action of imipramine are discussed. It is suggested that this drug merits further exploration in the most retarded, mute, anergic children, and in those with only borderline or little psychotic symptomatology.

References

  1. Alpers, H. S., & Himwich, H. E. An in vitro study of the effects of tricyclic antidepressant drugs on the accumulation of C14-serotonin by rabbit brain.Biological Psychiatry, 1969,1, 81–85.Google Scholar
  2. Axelrod, J., & Inscoe, J. K. The uptake and binding of circulating serotonin and the effect of drugs.Journal of Pharmacology and Experimental Therapeutics, 1963,141, 161–165.Google Scholar
  3. Borenstein, P., & Dabbah, M. Action of Tofranil (G22355) on the electroencephalogram.A nnales Medico-Psychologiques, 1959,117, 923–931.Google Scholar
  4. Boullin. D. J., Coleman, M., & O'Brien, R. A. Abnormalities in platelet 5-hydroxytryptaimine efflux in patients with infantile autism.Nature, 1970,226, 371–372.Google Scholar
  5. Campbell, M., Fish, B., Shapiro, T., & Floyd, A., Jr. Thiothixene in young disturbed children. A pilot study.Archives of General Psychiatry, 1970,2, 70–72.Google Scholar
  6. Campbell, M., Fish, B., Shapiro, T., & Floyd, A., Jr. Study of molindone in disturbed preschool children.Current Therapeutic Research, 1971,13, 28–33.Google Scholar
  7. Christe, P. Contribution to the study of depressions in children and their treatment with imipramine.Annales de Paediatrie, 1966,206, 47–83.Google Scholar
  8. Coppen, A., Shaw, D. M., Herzberg, B., & Maggs, R. Tryptophan in the treatment of depression.Lancet, 1967,2, 1179–1180.Google Scholar
  9. Costa, E. The role of serotonin in neurobiology.International Review of Neurobiology, 1960,2, 175–227.Google Scholar
  10. Crot, P. M. Preliminary investigation of tofranil in the treatment of children at the Swiss Medical-Pedagogical Office.Praxis, 1961,50, 202–206.Google Scholar
  11. Doepfner, W., & Cerletti, A. Comparison of lysergic acid derivatives and antihistamines as inhibitors of the edema provoked in the rat's paw by serotonin.International Archives of Allergy and Applied Immunology, 1958,12, 89–97.Google Scholar
  12. Fish, B. Drug therapy in child psychiatry: Pharmacological aspects.Comprehensive Psychiatry, 1960,1, 212–227.Google Scholar
  13. Fish, B. Evaluation of psychiatric therapies in children. In P. Hoch & J. Zubin (Eds.),The evaluation of psychiatric treatment. New York: Grune & Stratton, 1964.Google Scholar
  14. Fish, B. Methodology in child psychopharmacology. In D. H. Efron, J. O. Cole, J. Levine, & J. R. Wittenborn (Eds.),Psychopharmacology, review of progress (Public Health Service Publication No. 1836). Washington, D. C.: GOP, 1968, 989–1001.Google Scholar
  15. Fish, B., Campbell, M., Shapiro, T., & Floyd, A., Jr. Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: The value of less sedative antipsychotic agents.Current Therapeutic Research, 1969,11, 589–595. (a)Google Scholar
  16. Fish, B., Campbell, M., Shapiro, T., Floyd, A., Jr. Schizophrenic children treated with methysergide (Sansert).Diseases of the Nervous System, 1969,30, 534–540. (b)Google Scholar
  17. Fish, B., Shapiro, T., & Campbell, M. Long-term prognosis and the response of schizophrenic children to drug therapy: A controlled study of trifluoperazine.American Journal of Psychiatry, 1966,123, 32–39.Google Scholar
  18. Fish, B., Shapiro, T., Campbell, M., & Wile, R. A classification of schizophrenic children under five years.American Journal of Psychiatry, 1968,124, 1415–1423.Google Scholar
  19. Gershon, S., Holmberg, G., Mattsson, E., & Marshall, A. Imipramine hydrochloride. Its effects on clinical, autonomic and psychological functions.Archives of General Psychiatry, 1962,6, 96–101.Google Scholar
  20. Gesell, A., & Amatruda, C. S.Developmental diagnosis. New York: Harper, 1960.Google Scholar
  21. Greenblatt, M., Grosser, G. H., & Wechsler, H. Differential response of hospitalized depressed patients to somatic therapy.American Journal of Psychiatry, 1964,120, 935–943.Google Scholar
  22. Gyermek, L. Effects of imipramine-like anti-depressant agents on the autonomic nervous system. In D. H. Efron & S. S. Kety (Eds.),Antidepressant drugs of non-MAO inhibitor type. NIMH (NIH No. 1): Washington, D.C.: GPO, 1966, 41–62. (a)Google Scholar
  23. Gyermek, L. The pharmacology of imipramine and related antidepressants.International Review of Neurobiology, 1966,9, 95–143. (b)Google Scholar
  24. Gyermek, L., & Possemato, C. Potentiation of 5-hydroxytryptamine by imipramine.Medicina Experimentalis, 1960,3, 225–229.Google Scholar
  25. Hofmann, A. Recent developments in ergot alkaloids.Australasian Journal of Pharmacy, 1961,42, 7–18.Google Scholar
  26. Kajitani, T. Electroencephalographic studies of mentally retarded children. Part II. Effects of various psychotropic drugs on the electroencephalograms of mentally retarded children.Psychiatria et Neurologia Japonica, 1963,65, 211–223.Google Scholar
  27. Kiloh, L. G., Davison, K., & Osselton, J. W. An encephalographic study of the analeptic effects of imipramine.Electroencephalography and Clinical Neurophysiology, 1961,13, 216–223.Google Scholar
  28. Kivalo, E., Rinne, U. K., & Karinkanta, H. The effect of imipramine on the 5-hydroxytryptamine content and monoamine oxidase activity of the rat brain and on the excretion of 5-hydroxyindole acetic acid.Journal of Neurochemistry, 1961,8, 105–108.Google Scholar
  29. Klein, D., & Fink, M., Psychiatric reaction to imipramine.American Journal of Psychiatry, 1962,119, 432–438.Google Scholar
  30. Kuhn, R. The treatment of depressive states with G-22355 (imipramine hydrochloride).American Journal of Psychiatry, 1958,115, 459–464.Google Scholar
  31. Lapin, I. P., & Oxenkrug, G. F. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect.Lancet, 1969,1, 132–136.Google Scholar
  32. Murphy, D. L., Colburn, R. W., Davis, J. M., & Bunney, W. E. Imipramine and lithium effects on biogenic amine transport in depressed and manicdepressed patients.American Journal of Psychiatry, 1970,127, 339–345.Google Scholar
  33. Overall, J. E., Galveston, T., Hollister, L. E., Meyer, F., Kimbell, I., & Shelton, J. Imipramine and thioridazine in depressed and schizophrenic patients. Are there specific antidepressant drugs?Journal of American Medical Association, 1964,189, 605–608.Google Scholar
  34. Overall, J. E., Hollister, L. E., Johnson, M., & Pennington, V. Computer classifications of depressions and differential effect of antidepressants.Journal of the American Medical Association, 1965,192, 217.Google Scholar
  35. Persson, T., & Roos, B. E. 5-hydroxytryptophan for depression.Lancet, 1967,2, 987–988.Google Scholar
  36. Pollack, M., Klein, D. F., Willner, A., Blumberg, A., & Fink, M. Imipramine-induced behavioral disorganization in schizophrenic patients: Physiological and psychological correlates. In J. Wortis (Ed.),Recent advances in biological psychiatry. New York: Plenum Press, 1965.Google Scholar
  37. Pollin, W., Cardon, P. V., Jr., & Kety, S. S. Effects of amino acid feedings in schizophrenic patients treated with iproniazid.Science, 1961,133, 104–105.Google Scholar
  38. Rapoport, J. Childhood behavior and learning problems treated with imipramine.International Journal of Neuropsychiatry, 1965,1, 635–642.Google Scholar
  39. Raskin, A., Schulterbrandt, J. G., Reatig, N., Chase, C., & McKeon, J. J. Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.Archives of General Psychiatry, 1970,23, 164–173.Google Scholar
  40. Ritvo, E. R., Yuwiler, A., Geller, E., Kales, A., Rashkis, S., Schicor, A., Plotkin, S., Axelrod, R., & Howard, C. Effects of L-dopa in autism.Journal of Autism and Childhood Schizophrenia, 1971,1, 190–205.Google Scholar
  41. Ritvo, E. R., Yuwiler, A., Geller, E., Ornitz, E. M., Saeger, K., & Plotkin, S. Increased blood serotonin and platelets in early infantile autism.Archives of General Psychiatry, 1970,23, 566–572.Google Scholar
  42. Sigg, E. B., Soffer, L., & Gyermek, L. Influence of imipramine and related psychoactive agents on the effect of 5-hydroxytryptamine and catecholamines on the cat nictitating membrane.Journal of Pharmacology and Experimental Therapeutics, 1963,142, 13–20.Google Scholar
  43. Schain, R. J., & Freedman, D. X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.Journal of Pediatrics, 1961,58, 315–320.Google Scholar
  44. Schanberg, S. M., & Giarman, N. Drug induced alterations in the sub-cellular distribution of 5-hydroxytryptamine in rat's brain.Biochemical Pharmacology, 1962,11, 187–194.Google Scholar
  45. Shaffer, D., Costello, A. J., & Hill, I. D. Control of enuresis with imipramine.Archives of Diseases in Childhood, 1968,43, 665–671.Google Scholar
  46. Tec, L. Unexpected effects in children treated with imipramine.American Journal of Psychiatry, 1963,120, 603.Google Scholar
  47. Valentine, A. A., & Maxwell, C. Enuresis in severely subnormal children—A clinical trial of imipramine.Journal of Mental Subnormality, 1968,14, 84–90.Google Scholar
  48. Westman, M. Tofranil treatment of depressions in adolescence.Lakartidningen, 1965,62, (Suppl. 2), 87–92.Google Scholar

Copyright information

© Scripta Publishing Corporation 1971

Authors and Affiliations

  • Magda Campbell
    • 1
  • Barbara Fish
    • 1
  • Theodore Shapiro
    • 1
  • Arthur FloydJr.
    • 1
  1. 1.Department of PsychiatryNew York University School of MedicineUSA

Personalised recommendations